Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

Kalra, PR, Moon, J and Coats, AJ (2002) Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? American Heart Journal, 85 (2-3). pp. 195-197. ISSN 1097-6744

Full text not available from this repository.

Item Type:	Article
Faculty \ School:
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:13
Last Modified:	23 Oct 2022 19:33
URI:	https://ueaeprints.uea.ac.uk/id/eprint/15443
DOI:

Actions (login required)

View Item